JMS Co.,Ltd. engages in the manufacture, sale, export, and import of medical devices and pharmaceuticals in Japan, Asia, North America, Europe, China, South Korea, Thailand, and internationally. It offers infusion and nutrition solutions, which includes needless access port, closed drug mixing and infusion system, infusion pump, and oral and enteral nutrition system for treatment and laboratory testing; and dialysis solutions including dialysis equipment for hemodialysis, peritoneal dialysis solution, and APD equipment that automatically performs the injection and discharge of peritoneal dialysis solution, as well as offers hemodialysis machines. It also provides surgical treatment solution comprising products that are used in cardiac surgery and cardiovascular internal medicine, such as membrane oxygenator and cardiopulmonary blood pump systems. In addition, the company offers blood management and cell therapy solutions, which includes serum collection sets and blood bags. Further, it provides logistics and other equipment; and offers maintenance works and sanatorium services. The company was incorporated in 1947 and is headquartered in Hiroshima, Japan.
Visit company website
5 years, 5 months ago
JMS Co.,Ltd is currently in a long term downtrend where the price is trading 13.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
JMS Co.,Ltd's total revenue rose by 0.1% to $15B since the same quarter in the previous year.
Its net income has dropped by 31.9% to $367M since the same quarter in the previous year.
Based on the above factors, JMS Co.,Ltd gets an overall score of 2/5.